Back to Search
Start Over
[Atezolizumab in a first-line setting in non-small-cell lung cancer with high PD-L1 expression].
- Source :
-
Bulletin du cancer [Bull Cancer] 2021 Oct; Vol. 108 (10), pp. 904-906. Date of Electronic Publication: 2021 Sep 29. - Publication Year :
- 2021
- Subjects :
- Carcinoma, Non-Small-Cell Lung metabolism
Humans
Lung Neoplasms metabolism
Antibodies, Monoclonal, Humanized therapeutic use
Antineoplastic Agents therapeutic use
B7-H1 Antigen metabolism
Carcinoma, Non-Small-Cell Lung drug therapy
Immune Checkpoint Inhibitors therapeutic use
Lung Neoplasms drug therapy
Subjects
Details
- Language :
- French
- ISSN :
- 1769-6917
- Volume :
- 108
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- Bulletin du cancer
- Publication Type :
- Periodical
- Accession number :
- 34598788
- Full Text :
- https://doi.org/10.1016/j.bulcan.2021.06.011